119 related articles for article (PubMed ID: 30620048)
1. Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems.
Jorissen RN; Croxford M; Jones IT; Ward RL; Hawkins NJ; Gibbs P; Sieber OM
Int J Cancer; 2019 Jul; 145(1):132-142. PubMed ID: 30620048
[TBL] [Abstract][Full Text] [Related]
2. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
3. ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer.
Renfro LA; Grothey A; Xue Y; Saltz LB; André T; Twelves C; Labianca R; Allegra CJ; Alberts SR; Loprinzi CL; Yothers G; Sargent DJ;
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25359867
[TBL] [Abstract][Full Text] [Related]
4. Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer.
Weiser MR; Hsu M; Bauer PS; Chapman WC; González IA; Chatterjee D; Lingam D; Mutch MG; Keshinro A; Shia J; Vakiani E; Konishi T; Shimada Y; Stadler Z; Segal NH; Cercek A; Saltz L; Yaeger R; Varghese A; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash G; Paty P; Garcia-Aguilar J; Gonen M
J Clin Oncol; 2021 Mar; 39(8):911-919. PubMed ID: 33439688
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Overall Survival After Curative Colectomy in a Chinese Colon Cancer Population.
Liu M; Qu H; Bu Z; Chen D; Jiang B; Cui M; Xing J; Yang H; Wang Z; Di J; Chen L; Zhang C; Yao Z; Zhang N; Tan F; Gu J; Li Z; Su X
Ann Surg Oncol; 2015 Nov; 22(12):3881-7. PubMed ID: 25963477
[TBL] [Abstract][Full Text] [Related]
6. External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch population.
Bond MJG; Hamers PAH; Vink GR; van Grevenstein WMU; Laclé MM; van Smeden M; Koopman M; Roodhart JML; Punt CJA; May AM
Acta Oncol; 2022 May; 61(5):560-565. PubMed ID: 35253593
[TBL] [Abstract][Full Text] [Related]
7. The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort.
Huss A; Ihorst G; Timme-Bronsert S; Hasenburg A; Oehler MK; Klar M
Ann Surg Oncol; 2018 Dec; 25(13):3966-3973. PubMed ID: 30238246
[TBL] [Abstract][Full Text] [Related]
8. Stage II-III colon cancer: a comparison of survival calculators.
Lemini R; Attwood K; Pecenka S; Grego J; Spaulding AC; Nurkin S; Colibaseanu DT; Gabriel E
J Gastrointest Oncol; 2018 Dec; 9(6):1091-1098. PubMed ID: 30603128
[TBL] [Abstract][Full Text] [Related]
9. Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.
Papamichael D; Renfro LA; Matthaiou C; Yothers G; Saltz L; Guthrie KA; Van Cutsem E; Schmoll HJ; Labianca R; André T; O'Connell M; Alberts SR; Haller DG; Kountourakis P; Sargent DJ;
J Geriatr Oncol; 2016 Nov; 7(6):422-429. PubMed ID: 27468630
[TBL] [Abstract][Full Text] [Related]
10. Predicting Individualized Postoperative Survival for Stage II/III Colon Cancer Using a Mobile Application Derived from the National Cancer Data Base.
Gabriel E; Attwood K; Thirunavukarasu P; Al-Sukhni E; Boland P; Nurkin S
J Am Coll Surg; 2016 Mar; 222(3):232-44. PubMed ID: 26922599
[TBL] [Abstract][Full Text] [Related]
11. A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites.
Zhang Y; Ma J; Zhang S; Deng G; Wu X; He J; Pei H; Shen H; Zeng S
Int J Colorectal Dis; 2015 Sep; 30(9):1173-83. PubMed ID: 26054387
[TBL] [Abstract][Full Text] [Related]
12. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
13. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
14. Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study.
Lv Z; Liang Y; Liu H; Mo D
BMC Cancer; 2021 Mar; 21(1):306. PubMed ID: 33757442
[TBL] [Abstract][Full Text] [Related]
15. The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract dataset.
Dhahri A; Kaplan J; Naqvi SMH; Brownstein NC; Ntiri SO; Imanirad I; Felder SI; Dineen SP; Sanchez J; Dessureault S; Carballido E; Powers BD
Cancer Med; 2021 Aug; 10(16):5643-5652. PubMed ID: 34197047
[TBL] [Abstract][Full Text] [Related]
16. Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.
Jiang Y; Li T; Liang X; Hu Y; Huang L; Liao Z; Zhao L; Han Z; Zhu S; Wang M; Xu Y; Qi X; Liu H; Yang Y; Yu J; Liu W; Cai S; Li G
JAMA Surg; 2017 Jul; 152(7):e171087. PubMed ID: 28538950
[TBL] [Abstract][Full Text] [Related]
17. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
[TBL] [Abstract][Full Text] [Related]
18. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
[TBL] [Abstract][Full Text] [Related]
19. Alterations of lymph nodes evaluation after colon cancer resection: patient and tumor heterogeneity should be taken into consideration.
Guan X; Chen W; Li S; Jiang Z; Liu Z; Zhao Z; Wang S; Yang M; Wang X
Oncotarget; 2016 Sep; 7(38):62664-62675. PubMed ID: 27577077
[TBL] [Abstract][Full Text] [Related]
20. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
Abdel-Rahman O
Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
